If the sustainable-chemistry world has a holy grail, it’s turning carbon dioxide from threat into feedstock. And two start-ups are reporting advances in their quest to make CO 2 a feedstock for fuel: ...
Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...
Catalyst Pharmaceuticals management asserts a $1B+ LEMS market opportunity, estimating 3,600–5,400 addressable patients, with growth driven by improved diagnosis and market penetration. Recent ...
General Catalyst, a Silicon Valley-based venture firm with more than $43 billion in assets under management, has announced it plans to invest $5 billion in India over the next five years, sharply ...
Idaho National Laboratory (INL) has teamed up with artificial intelligence (AI) computing giant NVIDIA to advance “PROMETHEUS,” INL’s first-of-its-kind demonstration of an autonomous nuclear reactor ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer waited two years ...
Aluminum's journey has been remarkable, going from being more expensive than gold to one of the most widely used materials, from beverage cans to window frames and car parts. Scientists from the ...
Hosted on MSN
Ridley Scott’s 'Prometheus' streams on Netflix
The science-fiction thriller Prometheus is streaming on Netflix from today (16 February 2026). The movie follows a crew of a deep-space research vessel as they travel to a distant moon after ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Women exited the U.S. labor force in record numbers in 2025. A new national survey by the ...
It was older than the Roman Empire, the Egyptian pyramids and Christianity. Then someone cut it down. Now known as Prometheus, the bristlecone pine tree that found its home on Wheeler Peak in Nevada's ...
Worldwide Clinical Trials is expanding its horizons with the acquisition of Catalyst Clinical Research, a specialist oncology organization with a particular knack for early-stage cancer trials. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results